findmyKOL

Lynn Parker, MD

Basic profile

University of Louisville

ORCIDNone on fileNPI
RegionLouisville, KY · SoutheastSpecialtyGynecologic OncologyFocusOncology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Lynn Parker is an Oncology physician affiliated with University of Louisville. OpenAlex indexes 60 publications with 2,284 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
60publications

Distinct works indexed by OpenAlex.

2,284citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    30.4%
    Aromatase Inhibitor22.2%
    Anastrozole100%
    Part D<11 patients
    Poly(ADP-Ribose) Polymerase Inhibitor8.2%
    Rubraca100%
    Part D<11 patients
  • Respiratory

    24.6%
    Phenothiazine16.4%
    Promethazine Hcl100%
    Part D19 patients
    Opioid Agonist8.2%
    Hydrocodone-Acetaminophen100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    22.8%
    Serotonin-3 Receptor Antagonist22.8%
    Ondansetron Hcl100%
    Part D26 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”